selected scholarly activity
-
conferences
- Patterns of Failure after Stereotactic Radiosurgery vs. Whole Brain Radiotherapy for Resected Brain Metastases: Central Imaging Review of the N107C/CEC.3 (Alliance) Phase III Clinical Trial. International Journal of Radiation Oncology Biology Physics. 1063-1064. 2022
- PSMA-PET-BASED RESPONSE ASSESSMENT OF METASTATIC PROSTATE CANCER RESPONSE TO RADIOTHERAPY: A CASE SERIES. Radiotherapy and Oncology. S11-S11. 2021
- CCTG SC.24/TROG 17.06: A Randomized Phase II/III Study Comparing 24Gy in 2 Stereotactic Body Radiotherapy (SBRT) Fractions Versus 20Gy in 5 Conventional Palliative Radiotherapy (CRT) Fractions for Patients with Painful Spinal Metastases. International Journal of Radiation Oncology Biology Physics. 1397-1398. 2020
- EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS. Neuro-Oncology. 40-41. 2020
- Effect of Stereotactic Radiosurgery Compared to Whole-brain Radiotherapy for Limited Brain Metastasis on Long Term Cognition and Quality of Life: A Pooled Analysis of NCCTG N107C/CEC.3 and N0574 (Alliance) Randomized Clinical Trials. International Journal of Radiation Oncology Biology Physics. S175-S176. 2020
- Local Control After Resection And Adjuvant Radiosurgery Compared To Radiosurgery Alone For Brain Metastasis: Exploratory Analysis Of Alliance NCCTG N107C. International Journal of Radiation Oncology Biology Physics. e749-e750. 2020
- CYBERKNIFE STEREOTACTIC RADIOSURGERY FOR TREATMENT OF BENIGN INTRACRANIAL MENINGIOMA: LONG-TERM SAFETY AND EFFICACY. Radiotherapy and Oncology. S46-S47. 2019
- Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3). International Journal of Radiation Oncology Biology Physics. S10-S10. 2019
- N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS. Neuro-Oncology. 138-138. 2017
- PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933. Neuro-Oncology. 137-138. 2017
- N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease. International Journal of Radiation Oncology Biology Physics. 937-937. 2016
- Systematic Review of Patient-Reported Quality of Life Following Stereotactic Ablative Body Radiation Therapy for Primary and Metastatic Liver Cancer. International Journal of Radiation Oncology Biology Physics. E536-E537. 2016
- SYSTEMATIC REVIEW OF PATIENT REPORTED QUALITY OF LIFE FOLLOWING STEREOTACTIC ABLATIVE BODY RADIOTHERAPY FOR PRIMARY AND METASTATIC LIVER CANCER. Radiotherapy and Oncology. S62-S62. 2016
- RADIATION NECROSIS IN CHILDREN - AN UNDERREPORTED PROBLEM?!. Pediatric Blood and Cancer. S282-S283. 2015
- Survival in Patients With Brain Metastases From Non-Small Cell Lung Cancer Treated in the Radiosurgery Era. International Journal of Radiation Oncology Biology Physics. E434-E435. 2015
- Comparative Survival in Patients with Brain Metastases from Non-Small Cell Lung Cancer Treated before and after Implementation of Radiosurgery. Journal of Thoracic Oncology. S276-S276. 2015
- Evaluation of Pseudoprogression in Patients With Glioblastoma (EPPIG). International Journal of Radiation Oncology Biology Physics. S288-S288. 2014
- Stereotactic Radiosurgery for Refractory Trigeminal Neuralgia. International Journal of Radiation Oncology Biology Physics. S325-S326. 2014
- CogState computerized memory tests in patients with br ain metastases: Secondary endpoint results of RTOG 0933. Radiotherapy and Oncology. S5-S5. 2014
- MEMORY PRESERVATION WITH CONFORMAL AVOIDANCE OF THE HIPPOCAMPUS DURING WHOLE- BRAIN RADIOTHERAPY (WBRT) FOR PATIENTS WITH BRAIN METASTASES: PRELIMINARY RESULTS OF RTOG 0933. Neuro-Oncology. 94-95. 2013
- MEMORY PRESERVATION WITH CONFORMAL AVOIDANCE OF THE HIPPOCAMPUS DURING WHOLE-BRAIN RADIOTHERAPY FOR PATIENTS WITH BRAIN METASTASES: PRELIMINARY RESULTS OF RTOG 0933. Journal of Thoracic Oncology. S186-S186. 2013
- A Preliminary Series of the Use of Stereotactic Radiosurgery (SBRT) in High-Risk Head-and-Neck Cancer. International Journal of Radiation Oncology Biology Physics. S429-S430. 2013
- Robotic radiosurgery for the treatment of one to three brain metastases: A pragmatic application of cost-benefit analysis using willingness to pay.. Journal of Clinical Oncology. 17-17. 2012
- FRACTIONATED STEREOTACTIC RADIOSURGERY FOR RELAPSED PAEDIATRIC PRIMITIVE NEUROECTODERMAL TUMOURS: A SINGLE INSTITUTION EXPERIENCE. Neuro-Oncology. 146-146. 2012
- Fractionated Stereotactic Radiosurgery with Concurrent Temozolomide for Locally Recurrent Glioblastoma Multiforme: A Prospective Study. International Journal of Radiation Oncology Biology Physics. S281-S281. 2011
- A RETROSPECTIVE REVIEW OF THE INCIDENCE OF BRAIN METASTASES IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER. Neuro-Oncology. 844-844. 2008
- A RETROSPECTIVE REVIEW OF THE INCIDENCE OF BRAIN METASTASES IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER. Radiotherapy and Oncology. S52-S52. 2008
-
journal articles
- A Cancer Care Ontario Consensus-Based Organizational Guideline for the Planning and Delivery of Spine Stereotactic Body Radiation Therapy Treatment in Ontario. Practical Radiation Oncology. 13:499-509. 2023
- Fractionated Stereotactic Radiation for Central Nervous System Lymphoma: Retrospective Analysis of Initial Cases. Current Oncology. 30:8602-8611. 2023
- Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro-Oncology. 25:1123-1131. 2023
- Corrigendum to: Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro-Oncology. 25:1010-1010. 2023
- Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis. JAMA Oncology. 8:1809-1809. 2022
- The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers. Acta Neuropathologica. 144:1127-1142. 2022
- 18: PSMA-PET-Based Response Assessment of Metastatic Prostate Cancer Response to Radiotherapy: A Case Series. Radiotherapy and Oncology. 163:S11-S11. 2021
- Hypofractionated Stereotactic Radiotherapy for the Treatment of Benign Intracranial Meningiomas: Long-Term Safety and Efficacy. Current Oncology. 28:3683-3691. 2021
- Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial. The Lancet Oncology. 22:1023-1033. 2021
- Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Extent of Resection. Current Oncology. 28:2399-2408. 2021
- A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation. Radiation Oncology. 15:267. 2020
- CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS. Neuro-Oncology. 22:ii40-ii41. 2020
- CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS. Neuro-Oncology. 22:ii40-ii41. 2020
- 25. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF NCCTG N107C/CEC.3 AND N0574 (ALLIANCE) RANDOMIZED CLINICAL TRIALS. NOA. 2:ii4-ii4. 2020
- 25. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF NCCTG N107C/CEC.3 AND N0574 (ALLIANCE) RANDOMIZED CLINICAL TRIALS. Neuro-Oncology Advances. 2:ii4-ii4. 2020
- A Cancer Care Ontario Organizational Guideline for the Delivery of Stereotactic Radiosurgery for Brain Metastasis in Ontario, Canada. Practical Radiation Oncology. 10:243-254. 2020
- Neuro-Oncology Practice Clinical Debate: stereotactic radiosurgery or fractionated stereotactic radiotherapy following surgical resection for brain metastasis. Neuro-Oncology Practice. 7:263-267. 2020
- Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). International Journal of Radiation Oncology Biology Physics. 106:255-260. 2020
- Cervicomedullary hemangioblastoma treated with bevacizumab. NOA. 2:vdaa076. 2020
- 105 Cyberknife Stereotactic Radiosurgery for Treatment of Benign Intracranial Meningioma: Long-Term Safety and Efficacy. Radiotherapy and Oncology. 139:S46-S47. 2019
- Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933. Advances in Radiation Oncology. 4:579-586. 2019
- Using Magnetic Resonance Perfusion to Stratify Overall Survival in Treated High-Grade Gliomas. Canadian Journal of Neurological Sciences. 46:533-539. 2019
- RADI-04. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933. NOA. 1:i22-i22. 2019
- RADI-04. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933. Neuro-Oncology Advances. 1:i22-i22. 2019
- Incidence of Radionecrosis in Single-Fraction Radiosurgery Compared with Fractionated Radiotherapy in the Treatment of Brain Metastasis. Current Oncology. 26:328-333. 2019
- 33 Is hypofractionation safer than single-fraction radio surgery? The effect of fractionation on radionecrosis. Canadian Journal of Neurological Sciences. 45:S6-S7. 2018
- The Future Is Now—Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018!. Frontiers in Oncology. 8:380. 2018
- Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer. Radiation Oncology. 12:110. 2017
- NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933. Neuro-Oncology. 19:vi137-vi138. 2017
- NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS. Neuro-Oncology. 19:vi138-vi138. 2017
- NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933. Neuro-Oncology. 19:vi137-vi138. 2017
- NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS. Neuro-Oncology. 19:vi138-vi138. 2017
- Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. The Lancet Oncology. 18:1049-1060. 2017
- Evaluation of pseudoprogression in patients with glioblastoma. Neuro-Oncology Practice. 4:120-134. 2017
- A randomized phase II/III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for patients with spinal metastases (NCT02512965).. Journal of Clinical Oncology. 35:TPS10129-TPS10129. 2017
- Comparative Survival in Patients with Brain Metastases from Non-small-Cell Lung Cancer Treated before and after Implementation of Radiosurgery. Current Oncology. 24:146-151. 2017
- Clinical Surveillance Compared with Clinical and Magnetic Resonance Imaging Surveillance for Brain Metastasis: A Feasibility Survey. Current Oncology. 23:356-360. 2016
- 169: Systematic Review of Patient Reported Quality of Life Following Stereotactic Ablative Body Radiotherapy for Primary and Metastatic Liver Cancer. Radiotherapy and Oncology. 120:S62-S62. 2016
- The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer. Technology in Cancer Research and Treatment. 15:171-178. 2016
- CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933. Journal of Neuro-Oncology. 126:327-336. 2016
- NIMG-27USING MR PERFUSION TO STRATIFY PATIENTS WITH TREATED HIGH-GRADE GLIOMAS: DOES IT CORRELATE WITH OVERALL SURVIVAL?. Neuro-Oncology. 17:v159.3-v159. 2015
- NIMG-27USING MR PERFUSION TO STRATIFY PATIENTS WITH TREATED HIGH-GRADE GLIOMAS: DOES IT CORRELATE WITH OVERALL SURVIVAL?. Neuro-Oncology. 17:v159-v159. 2015
- Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. Neuro-Oncology. 17:868-881. 2015
- Innovation: Development of a Virtual Radiation Oncologist Consultation Service. Journal of Medical Imaging and Radiation Sciences. 46:S5-S5. 2015
- Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial. Journal of Clinical Oncology. 32:3810-3816. 2014
- Stereotactic radiosurgery for refractory trigeminal neuralgia. Canadian Journal of Neurological Sciences. 41:S15-S15. 2014
- Brain Metastases in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 15:249-257. 2014
- Utilization of Stereotactic Ablative Radiotherapy in the Management of Oligometastatic Disease. Current Oncology. 21:115-117. 2014
- Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study. OncoTargets and Therapy. 7:485-485. 2014
- PO-0661: CogState computerized memory tests in patients with br ain metastases: Secondary endpoint results of RTOG 0933. Radiotherapy and Oncology. 111:S5-S5. 2014
- Memory Preservation With Conformal Avoidance of the Hippocampus During Whole-Brain Radiation Therapy for Patients With Brain Metastases: Primary Endpoint Results of RTOG 0933. International Journal of Radiation Oncology Biology Physics. 87:1186-1186. 2013
- Robotic Radiosurgery for the Treatment of 1–3 Brain Metastases: A Pragmatic Application of Cost-Benefit Analysis Using Willingness-To-Pay. Technology in Cancer Research and Treatment. 12:517-523. 2013
- The Technique and Cost of Radiosurgery for the Treatment of 1-3 Brain Metastases. Canadian Journal of Neurological Sciences. 40:795-799. 2013
- Technology Resource Planning in Radiation Oncology: Application of a Needs-Based Analytic Framework to Radiosurgery Planning in Ontario. JCO Oncology Practice. 8:358-362. 2012
- Selecting Patients with Extensive-Stage Small Cell Lung Cancer for Prophylactic Cranial Irradiation by Predicting Brain Metastases. Journal of Thoracic Oncology. 6:808-812. 2011
- Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment. British Journal of Surgery. 84:1099-1103. 1997
- Karyometry in the Estimation of Nuclear Population in Pulmonary Carcinomas2. Journal of the National Cancer Institute. 52:1699-1704. 1974
-
preprints